5-Fluoro-2-methyl-N-[4-(5H-pyrrolo[2,1-c]- [1,4]benzodiazepin-10(11H)-ylcarbonyl)-3- chlorophenyl]benzamide (VPA-985): An Orally Active Arginine Vasopressin Antagonist with Selectivity for V₂Receptors

This publication has 19 references indexed in Scilit:

• Abstract
  Journal of the American College of Cardiology, 1997
• Rat renal arcade segment expresses vasopressin-regulated water channel and vasopressin V2 receptor.
  Journal of Clinical Investigation, 1996
• Orally Active, Nonpeptide Vasopressin V₂ Receptor Antagonists: A Novel Series of 1-[4-(Benzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepines and Related Compounds
  Journal of Medicinal Chemistry, 1996
• Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.
  Journal of Clinical Investigation, 1993
• Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.
  Journal of Clinical Investigation, 1993
• Cloning of the Human Type‐2 Vasopressin Receptor Gene
  Annals of the New York Academy of Sciences, 1993
• Molecular cloning of the receptor for human antidiuretic hormone
  Nature, 1992
• Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues
  Life Sciences, 1992
• OPC-21268, an Orally Effective, Nonpeptide Vasopressin V1 Receptor Antagonist
  Science, 1991
• Synthesis of syn and anti isomers of 6-[[(hydroxyimino)phenyl]methyl]-1-[(1-methylethyl)sulfonyl]-1H-benzimidazol-2-amine. Inhibitors of rhinovirus multiplication
  Journal of Medicinal Chemistry, 1980